The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $119.802 million which beat the analyst consensus estimate of $114.600 million by 4.54 percent. This is a 21.53 percent increase over sales of $98.578 million the same period last year.